Cocaine and beta-blockers: The paradigm

European Journal of Internal Medicine

Volumn 21, Issue 2, 2010, Pages 84-86

  Damodaran, Senthilkumar ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Acute coronary syndrome; Beta blockers; Carvedilol; Cocaine

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE DERIVATIVE; BENZOYLECGONINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; COCAINE; DIAZEPAM; ESMOLOL; GLYCERYL TRINITRATE; LABETALOL; METOPROLOL; PROPRANOLOL;

ACUTE CORONARY SYNDROME; ANXIETY DISORDER; ATHEROSCLEROSIS; CORONARY ARTERY ANEURYSM; CORONARY ARTERY CONSTRICTION; DRUG WITHDRAWAL; HEART INFARCTION; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; INTOXICATION; NONHUMAN; REVIEW; SCREENING; TACHYCARDIA; THORAX PAIN; THROMBOSIS; TREATMENT CONTRAINDICATION; VASOSPASM; WITHDRAWAL SYNDROME;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; BRAIN; CARBAZOLES; CARDIOVASCULAR SYSTEM; COCAINE; COCAINE-RELATED DISORDERS; HUMANS; PROPANOLAMINES;

EID: 77649188168     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.11.010     Document Type: Review

References (32)

1. Nutt D., King L.A., Saulsbury W., and Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 369 (2007) 1047-1053
2. Brody S.L., Slovis C.M., and Wrenn K.D. Cocaine-related medical problems: consecutive series of 233 patients. Am J Med 88 (1990) 325-331
3. Hollander J.E., Hoffman R.S., Gennis P., et al. Cocaine-associated chest pain: one-year follow-up. Acad Emerg Med 2 (1995) 179-184
4. Weber J.E., Chudnofsky C.R., Boczar M., Boyer E.W., Wilkerson M.D., and Hollander J.E. Cocaine-associated chest pain: how common is myocardial infarction?. Acad Emerg Med 7 (2000) 873-877
5. Lange R.A., Cigarroa R.G., Yancy Jr. C.W., et al. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med 321 (1989) 1557-1562
6. Afonso L., Mohammad T., and Thatai D. Crack whips the heart: a review of the cardiovascular toxicity of cocaine. Am J Cardiol 100 (2007) 1040-1043
7. Moliterno D.J., Lange R.A., Gerard R.D., Willard J.E., Lackner C., and Hillis L.D. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med 96 (1994) 492-496
8. Dressler F.A., Malekzadeh S., and Roberts W.C. Quantitative analysis of amounts of coronary arterial narrowing in cocaine addicts. Am J Cardiol 65 (1990) 303-308
9. Om A., Ellahham S., and DiSciascio G. Management of cocaine-induced cardiovascular complications. Am Heart J 125 (1993) 469-475
10. Wallace J.E., Hamilton H.E., King D.E., Bason D.J., Schwertner H.A., and Harris S.C. Gas-liquid chromatographic determination of cocaine and benzoylecgonine in urine. Anal Chem 48 (1976) 34-38
11. Linder M.W., Bosse G.M., Henderson M.T., Midkiff G., and Valdes R. Detection of cocaine metabolite in serum and urine: frequency and correlation with medical diagnosis. Clin Chim Acta 295 (2000) 179-185
12. Brogan III W.C., Lange R.A., Kim A.S., Moliterno D.J., and Hillis L.D. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 18 (1991) 581-586
13. Rappolt R.T., Gay G.R., and Inaba D.S. Propranolol: a specific antagonist to cocaine. Clin Toxicol 10 (1977) 265-271
14. Rappolt R.T., Gay G., Inaba D.S., and Rappolt N.R. Propranolol in cocaine toxicity. Lancet 2 (1976) 640-641
15. Catravas J.D., and Waters I.W. Acute cocaine intoxication in the conscious dog: studies on the mechanism of lethality. J Pharmacol Exp Ther 217 (1981) 350-356
16. Ramoska E., and Sacchetti A.D. Propranolol-induced hypertension in treatment of cocaine intoxication. Ann Emerg Med 14 (1985) 1112-1113
17. Sand I.C., Brody S.L., Wrenn K.D., and Slovis C.M. Experience with esmolol for the treatment of cocaine-associated cardiovascular complications. Am J Emerg Med 9 (1991) 161-163
18. Kenny D., Pagel P.S., and Warltier D.C. Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol. Basic Res Cardiol 87 (1992) 465-477
19. Boehrer J.D., Moliterno D.J., Willard J.E., Hillis L.D., and Lange R.A. Influence of labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 94 (1993) 608-610
20. Sofuoglu M., Brown S., Babb D.A., Pentel P.R., and Hatsukami D.K. Effects of labetalol treatment on the physiological and subjective response to smoked cocaine. Pharmacol Biochem Behav 65 (2000) 255-259
21. Briggs R.S., Birtwell A.J., and Pohl J.E. Hypertensive response to labetalol in phaeochromocytoma. Lancet 1 (1978) 1045-1046
22. Spivey W.H. Flumazenil and seizures: analysis of 43 cases. Clin Ther 14 (1992) 292-305
23. Frishman W.H. Carvedilol. N Engl J Med 339 (1998) 1759-1765
24. Sofuoglu M., Brown S., Babb D.A., Pentel P.R., and Hatsukami D.K. Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug Alcohol Depend 60 (2000) 69-76
25. Rudoy C.A., and Van Bockstaele E.J. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 1119-1129
26. Kelley B.J., Yeager K.R., Pepper T.H., Bornstein R.A., and Beversdorf D.Q. The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal. Neurocase 13 (2007) 320-327
27. Dattilo P.B., Hailpern S.M., Fearon K., Sohal D., and Nordin C. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 51 (2008) 117-125
28. Missouris C.G., Swift P.A., and Singer D.R. Cocaine use and acute left ventricular dysfunction. Lancet 357 (2001) 1586
29. Blaho K., Winbery S., Park L., and Gresham H.W. Cocaine use and acute coronary syndromes. Lancet 358 (2001) 1368
30. Henning R.J., and Li Y. Cocaine produces cardiac hypertrophy by protein kinase C dependent mechanisms. J Cardiovasc Pharmacol Ther 8 (2003) 149-160
31. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50 (2007) e1-e157
32. Page II R.L., Utz K.J., and Wolfel E.E. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome?. Ann Pharmacother 41 (2007) 2008-2013